Showing results (11-20 of 329) with videos related to
Sort By:
Pageof 33
Expert Opinion on Pharmacotherapy|December 21, 2022
Current advances in the pharmacological prevention and management of cognitive dysfunction in multiple sclerosisAngelo Bellinvia, Emilio Portaccio, Maria Pia AmatoExpert Review of Neurotherapeutics|October 22, 2008
Cognitive changes in multiple sclerosisMaria Pia Amato, Valentina Zipoli, Emilio PortaccioCurrent Opinion in Neurology|April 10, 2026
Cognition in multiple sclerosisErmelinda De Meo, Emilio Portaccio, Maria Pia AmatoBrain Sciences|April 3, 2021
Cognitive Issues in Pediatric Multiple SclerosisEmilio Portaccio, Ermelinda De Meo, Angelo Bellinvia, et al.Journal of the Neurological Sciences|September 18, 2007
Intravenous mitoxantrone and cyclophosphamide as second-line therapy in multiple sclerosis: an open-label comparative study of efficacy and safetyValentina Zipoli, Emilio Portaccio, Bahia Hakiki, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|July 26, 2012
Withdrawal of fingolimod treatment for relapsing-remitting multiple sclerosis: report of six casesBahia Hakiki, Emilio Portaccio, Marta Giannini, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 14, 2025
Multiple sclerosis and sickle cell anemia: when two worlds collideMatteo Betti, Cristina Giubbilei, Simona D'angelo, et al.The Clinical Neuropsychologist|June 1, 2004
Changes in neuropsychological test performance over the workday in multiple sclerosisWilliam W Beatty, Benedetta Goretti, Gianfranco Siracusa, et al.Journal of the Neurological Sciences|April 10, 2014
Emotional and neutral verbal memory impairment in Multiple SclerosisPietro Iaffaldano, Rosa Gemma Viterbo, Benedetta Goretti, et al.Expert Review of Neurotherapeutics|January 13, 2025
An update on the treatment and management of cognitive dysfunction in patients with multiple sclerosisErmelinda De Meo, Emilio Portaccio, Raffaello Bonacchi, et al.Pageof 33